The Secret Sauce Behind High-Enrolling PIs: Aligning Sponsor And PI Incentives To Unlock Enrollment

Sponsors often assume slow enrollment is a patient identification problem. But despite bigger recruitment campaigns, enrollment rates continue to stagnate. The real challenge often comes later, at the screening stage, where PI prioritization, site bandwidth, and sponsor support have everything to do with how many patients actually make it onto a study.

Dr. Marat Fudim, a Duke cardiologist and PI on numerous active studies, joins Dr. Bimal Shah, a cardiologist, former Duke research leader, and health-tech executive, in a discussion moderated by John St. Clair of TruTechnologies. Together, they reveal the “secret sauce” that sets high-enrolling investigators apart, and what sponsors can do to better support PIs and the teams behind them.